Spinal Instability Neoplastic Score (SINS)
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Stable0–6
- Potentially unstable7–12
- Unstable13–18
The Spinal Instability Neoplastic Score (SINS) calculates staging malignant disease, estimating overall survival, and assessing chemotherapy tolerability. Key inputs include location. Scores guide adjusting systemic antineoplastic regimens, planning supportive palliative measures, or targeted monitoring. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Spinal Instability Neoplastic Score (SINS): quantifies spinal instability in patients with spinal metastases across 6 components (location, pain, bone lesion, alignment, vertebral collapse, posterolateral involvement). Total 0-18; higher scores indicate greater instability and need for surgical consultation.
Clinical Indication
The Spinal Instability Neoplastic Score (SINS) is indicated for bedside clinical practice to support Spinal Instability Neoplastic Score (SINS): quantifies spinal instability in patients with spinal metastases across 6 components (location, pain, bone lesion, alignment, vertebral collapse, posterolateral involvement). Total 0-18; higher scores indicate greater instability and need for surgical consultation.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients with solid tumors or hematologic malignancies undergoing staging, systemic therapy tolerability assessment, or prognostic stratification. Clinical application is indicated across Medical oncology clinics, chemotherapy infusion suites, inpatient oncology services, and palliative care.
Limitations & Contraindications
Prognostic indices provide statistical cohort survival estimates and must not replace individualized patient goals of care.
Clinical Pearls & Action Plan
Standardized functional performance status (ECOG or Karnofsky) is an independent determinant of chemotherapy tolerance and survival.
SINS = location (0-3) + pain (0-3) + bone lesion (0-2) + alignment (0-4) + vertebral collapse (0-3) + posterolateral involvement (0-3)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| location | string | Yes | Spinal location of the lesion |
| pain | string | Yes | Pain character |
| bone_lesion | string | Yes | Bone lesion type on imaging |
| alignment | string | Yes | Radiographic spinal alignment |
| vertebral_collapse | string | Yes | Vertebral body collapse |
| posterolateral_involvement | string | Yes | Posterolateral element involvement (pedicles, facets) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–6 | Stable | Stable spine |
| 7–12 | Potentially unstable | Potentially unstable - surgical consultation advised |
| 13–18 | Unstable | Unstable - surgical consultation recommended |
Evidence-Based References (EBM)
- Fisher CG, DiPaola CP, Ryken TC, et al. A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and the Spinal Instability Neoplastic Score. Spine (Phila Pa 1976). 2010;35(22):E1221-E1229.
Related calculators
- Spinal Instability Neoplastic Score (SINS)
- Khorana Risk Score for Venous Thromboembolism in Cancer Patients
- Memorial Sloan-Kettering Cancer Center (MSKCC/Motzer) Score for Metastatic Renal Cell Carcinoma (RCC)
- Modified Glasgow Prognostic Score (mGPS) for Cancer Outcomes
- Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) Score